Recruiting studies: Adenomatous Polyposis Coli Apc Gene Mutation

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma
Phase 1/Phase 2 · 1 location(s) · HonorHealth Research Institute · NCT07463599 An Intervention to Increase Genetic Testing in Families Who May Share a Gene Mutation Related to Cancer Risk and An Inte
NA · 8 location(s) · Memorial Sloan Kettering Cancer Center · NCT05420064 FOG-001 in Locally Advanced or Metastatic Solid Tumors
Phase 1/Phase 2 · 33 location(s) · Parabilis Medicines, Inc. · NCT05919264 Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)
Phase 1/Phase 2 · 17 location(s) · Recursion Pharmaceuticals Inc. · NCT05552755 Duodenal Polyposis Classification in FAP
Phase N/A · 2 location(s) · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · NCT07199127

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.